ConductScience.org, home

Paper2178792

A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIP.

Foster BJ and 5 others. Cancer Chemother Pharmacol, 1990. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIP. Papers, record 2178792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2178792

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIP.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1990
PubMed
Publication types
Comparative Study, Journal Article, Review
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
0.76
iCite
Revised in PubMed
2026-10-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Foster BJB J
2Harding BJB J
3Wolpert-DeFilippes MKM K
4Rubinstein LYL Y
5Clagett-Carr KK
6Leyland-Jones BB

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
CisplatinMajor topic
Organoplatinum CompoundsMajor topic
Animals
Carboplatin
Chemical Phenomena
Chemistry
Drug Design
Drug Evaluation
Drug Screening Assays, Antitumor
Humans
Leukemia L1210
Male
Mice
Neoplasms, Experimental
Rats
Rats, Inbred F344

Source PubMed

Download CSV of topics

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1761445Kinetics of cis-dichlorodiammineplatinum.Clin Pharmacol Ther1979https://conductscience.org/library/papers/761445PubMed
24586953Cis-diamminedichloroplatinum (NSC-119875): a phase I study.Cancer Chemother Rep1973https://conductscience.org/library/papers/4586953PubMed
35479434Inhibitory effects of anti-tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in virtro.Int J Cancer1970https://conductscience.org/library/papers/5479434PubMed
4387222Mode of DNA binding of cis-platinum(II) antitumor drugs: a base sequence-dependent mechanism is proposed.Cancer Treat Rep1979https://conductscience.org/library/papers/387222PubMed
57194166Clinical kinetics on intact cisplatin and some related species.Clin Pharmacol Ther1981https://conductscience.org/library/papers/7194166PubMed
66392147A phase I trial of cis-diammine-1,1-cyclobutane dicarboxylate platinum II (Carboplatin, CBDCA, JM-8) with a single dose every five week-schedule.Invest New Drugs1984https://conductscience.org/library/papers/6392147PubMed
74689325Binding of cis- and trans-dichlorodiammineplatinum(II) to nucleosides. I. Location of the binding sites.J Am Chem Soc1973https://conductscience.org/library/papers/4689325PubMed
8498150Antileukemia (L1210) activity and toxicity of cis-dichlorodiammineplatinum(II) analogs.Cancer Treat Rep1979https://conductscience.org/library/papers/498150PubMed
91174534X-ray photoelectron spectroscopy of DNA-Pt complexes. Evidence of O6 (Gua)-N7 (Gua) chelation of DNA with cis- dichlorodiamine platinum(II).Biochim Biophys Acta1975https://conductscience.org/library/papers/1174534PubMed
10498145Anticancer activity of cis-dichlorodiammineplatinum(II) and some relevant chemistry.Cancer Treat Rep1979https://conductscience.org/library/papers/498145PubMed
117191777Effects of second-generation platinum analogs on isolated PM-2 DNA and their cytotoxicity in vitro and in vivo.Cancer Res1980https://conductscience.org/library/papers/7191777PubMed
126272211Use of exonuclease III to determine the site of stable lesions in defined sequences of DNA: the cyclobutane pyrimidine dimer and cis and trans dichlorodiammine platinum II examples.Nucleic Acids Res1981https://conductscience.org/library/papers/6272211PubMed
134551181Cross-linking of complementary strands of DNA in mammalian cells by antitumour platinum compounds.Nature1972https://conductscience.org/library/papers/4551181PubMed
147199380Comparative studies of DNA cross-linking and cytotoxicity in Burkitt's lymphoma cell lines treated with cis-diamminedichloroplatinum(II) and L-phenylalanine mustard.Cancer Res1982https://conductscience.org/library/papers/7199380PubMed
156367971Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function.Cancer Res1984https://conductscience.org/library/papers/6367971PubMed
162674333A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study.J Clin Oncol1989https://conductscience.org/library/papers/2674333PubMed
176883623Pharmacokinetics of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV (CHIP) in patients with advanced cancer.Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6883623PubMed
183510700Phase I clinical trial and pharmacokinetics of carboplatin (NSC 241240) by single monthly 30-minute infusion.Cancer1986https://conductscience.org/library/papers/3510700PubMed
19291481Platinum analogs of clinical interest.Cancer Treat Rep1979https://conductscience.org/library/papers/291481PubMed
206761010Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6761010PubMed

See all 48 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
8512813
A new anticancer platinum compound, (-)-(R)-2-aminomethyl-pyrrolidine(1,1-cyclobutanedicarboxylato) platinum(II): DNA interstrand crosslinking, repair and lethal effects in normal human, Fanconi's anaemia and xeroderma pigmentosum cells.
Br J Cancer1993https://conductscience.org/library/papers/8512813PubMed
8453687Pharmacokinetics of (1R,2R-diaminocyclohexane)oxalatoplatinum(II) in comparison with cisplatin following a single intravenous injection in rabbits.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8453687PubMed
8258189Combination treatment of cis- and carboplatin in cancers restricted to the peritoneal cavity in the rat.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8258189PubMed
7981487New platinum agents. A comparison in ovarian cancer.Drugs Aging1994https://conductscience.org/library/papers/7981487PubMed
1906857Toxicological and tumoricidal evaluations of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)platinum( II) monohydrate, in rats.Jpn J Cancer Res1991https://conductscience.org/library/papers/1906857PubMed
1583000Serum-free media for murine erythroleukemia cells still not as good as serum-supplemented media.In Vitro Cell Dev Biol1992https://conductscience.org/library/papers/1583000PubMed
1503895Modulation of cis-diamminedichloroplatinum(II) resistance: a review.Br J Cancer1992https://conductscience.org/library/papers/1503895PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2178792

GET https://conductscience.org/api/papers/v1/2178792/references?page=2